The elevated expression of METTL3 in CRC could increase the m6A level of GLUT1 and promote its mRNA translation, leading to higher glucose uptake and lactate production which subsequently activated mTORC1 signaling [75]. The gene discussed is SLC2A1; the disease is colorectal carcinoma.